CN1421450A - 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤的制备方法 - Google Patents
9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤的制备方法 Download PDFInfo
- Publication number
- CN1421450A CN1421450A CN 02151031 CN02151031A CN1421450A CN 1421450 A CN1421450 A CN 1421450A CN 02151031 CN02151031 CN 02151031 CN 02151031 A CN02151031 A CN 02151031A CN 1421450 A CN1421450 A CN 1421450A
- Authority
- CN
- China
- Prior art keywords
- catalyst
- ethyl
- methyl
- vitamin
- phosphoroso
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021510318A CN1139597C (zh) | 2002-12-04 | 2002-12-04 | 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021510318A CN1139597C (zh) | 2002-12-04 | 2002-12-04 | 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1421450A true CN1421450A (zh) | 2003-06-04 |
CN1139597C CN1139597C (zh) | 2004-02-25 |
Family
ID=4751891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021510318A Expired - Fee Related CN1139597C (zh) | 2002-12-04 | 2002-12-04 | 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1139597C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702204A (zh) * | 2012-06-25 | 2012-10-03 | 江苏济川制药有限公司 | 一种制备替比培南匹伏酯的方法 |
CN104666315A (zh) * | 2010-12-10 | 2015-06-03 | 西格玛制药实验有限责任公司 | 口服活性核苷酸类似物或口服活性核苷酸类似物前药的高度稳定组合物 |
-
2002
- 2002-12-04 CN CNB021510318A patent/CN1139597C/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104666315A (zh) * | 2010-12-10 | 2015-06-03 | 西格玛制药实验有限责任公司 | 口服活性核苷酸类似物或口服活性核苷酸类似物前药的高度稳定组合物 |
CN102702204A (zh) * | 2012-06-25 | 2012-10-03 | 江苏济川制药有限公司 | 一种制备替比培南匹伏酯的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1139597C (zh) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100351240C (zh) | 瑞舒伐他汀钙的合成方法 | |
CN1178665C (zh) | 唑系化合物的水溶性前药 | |
CN1821242A (zh) | 制备二羟基酸HMG-CoA还原酶抑制剂的新方法 | |
CN1098101A (zh) | 虾青素的制备、制备它的新中间体以及其制备 | |
CN101418017A (zh) | (r)-9-(2-磷酸甲氧基丙基)腺嘌呤的合成方法 | |
CN1139597C (zh) | 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤的制备方法 | |
CN1130330C (zh) | 制备琥珀酰基琥珀酸二烷基酯类化合物的方法 | |
CN1844077A (zh) | 1-氯-2-甲基-4-烃酰氧基-2-丁烯制备方法 | |
CN1029965C (zh) | 具有氨基噻唑(亚氨基氧基乙酸)乙酸侧链的β-内酰胺的制备方法 | |
US20170354668A1 (en) | Synthesis Method For Improved Tenofovir Disoproxil Fumarate Using Ion-Exchange Resin And Method For Preparing Oral Dissolving Film Form Using The Same | |
CN101061128A (zh) | 制备二异丙基((1-(羟甲基)-环丙基)氧)甲基膦酸脂的方法 | |
WO2012017441A1 (en) | Improved process to prepare s-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid | |
CN103804414B (zh) | 用于制备瑞舒伐他汀钙的中间体化合物以及由其制备瑞舒伐他汀钙的方法 | |
CN102199132A (zh) | 2-(2-氨基-4-噻唑)-2(z)-[[(叔丁氧羰基)甲氧]亚氨]乙酸及其盐的制备方法 | |
CN1634943A (zh) | 一组非环核苷酸类似物及其合成方法和在抗病毒中的应用 | |
CN1160354C (zh) | 合成氯嘌呤中间体的方法 | |
RU2497803C2 (ru) | Промежуточные продукты в синтезе аналогов зеараленоновых макролидов | |
CN1142170C (zh) | 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤晶体,制备方法和晶体的应用 | |
CN100340557C (zh) | 具有神经镇静活性的齐拉西酮的酰基衍生物 | |
CN112358490A (zh) | 一种盐酸四咪唑的制备方法 | |
CN104230987A (zh) | 一种[1-卤代-(2-丙氧基)]-甲基膦酸类化合物及其制备和应用 | |
CN1146547C (zh) | 4,6-二氯-5-氟嘧啶的制备方法 | |
CN1421451A (zh) | 9-[2-[[[双(三甲基乙酰氧)甲基]氧磷基]甲氧基]-乙基]腺嘌呤晶体,制备方法和晶体的应用 | |
CN101058588A (zh) | 一种合成阿德福韦的方法 | |
CN1740155A (zh) | 选择性合成氟伐他汀的中间体及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI YISHENGYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI RUIGUANG BIOCHEMICAL TECHNOLOGY DEVELOPMENT CO., LTD.; LI QISHENG Effective date: 20060609 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060609 Address after: 201318 Shanghai city Nanhui District Zhoupu town inntech Road No. 98 Patentee after: Shanghai Yishengyuan Pharmaceutical Co., Ltd. Address before: 902 room 1, 200002 Ningbo Road, Shanghai Co-patentee before: Li Qisheng Patentee before: Shanghai Ruiguang Biochemical Sci-Tech Development Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20091015 Pledge (preservation): Pledge |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100429 Granted publication date: 20040225 Pledgee: Agricultural Bank of China, Limited by Share Ltd, Shanghai, Nanhui branch Pledgor: Shanghai Yishengyuan Pharmaceutical Co., Ltd. Registration number: 2009310000627 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040225 Termination date: 20201204 |